SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-245865
Filing Date
2020-09-15
Accepted
2020-09-15 09:09:01
Documents
15
Period of Report
2020-09-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d50689d8k.htm   iXBRL 8-K 24734
2 EX-99.1 d50689dex991.htm EX-99.1 18194
6 GRAPHIC g50689g11e36.jpg GRAPHIC 37041
7 GRAPHIC g50689g36h69.jpg GRAPHIC 37367
  Complete submission text file 0001193125-20-245865.txt   268261

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acet-20200915.xsd EX-101.SCH 2729
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acet-20200915_lab.xml EX-101.LAB 18859
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acet-20200915_pre.xml EX-101.PRE 11836
8 EXTRACTED XBRL INSTANCE DOCUMENT d50689d8k_htm.xml XML 3458
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 201174848
SIC: 2834 Pharmaceutical Preparations